Risk factors associated with unknown prevalent cases were elevated liver enzymes (but not ALT), inflammatory markers, markers of NASH and hepatic fibrosis (all P < 0.01, Tables 2 and 3). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.